Differences in clinical use between domestic and imported drugs of Imatinib
Imatinib (Imatinib) is a drug that targets BCR-ABL tyrosine kinase and is widely used in the treatment of chronic myelogenous leukemia (CML) and some gastrointestinal stromal tumors (GIST). Currently, there are both domestic versions and imported original drugs on the domestic market. Patients need to understand the differences between the two when choosing.
Domestic imatinib is usually more affordable in terms of price. The common specifications are 100mg*60 tablets. The market price is around six to seven hundred yuan, and it has been included in the scope of medical insurance reimbursement, making the financial burden on patients who take the medicine for a long time relatively small. In clinical use, the main ingredients and efficacy of domestic drugs and original drugs are basically the same, but there may be slight differences in excipients, production processes and tablet dissolution rates, and they need to be used under the guidance of a doctor.

The efficacy and stability of imported original imatinib have been clinically verified for a long time, and the clinical efficacy is reliable. It is especially suitable for patients with high efficacy requirements or special medical needs. Imported medicines are usually beautifully packaged and have good tablet consistency. The incidence of side effects is similar to that of domestic medicines, but the price is significantly higher than that of domestic medicines. The price of each box usually ranges from a few thousand yuan to tens of thousands of yuan.
In terms of clinical application, regardless of whether they choose domestic or imported drugs, patients must follow the doctor's dosage and course of treatment instructions, and regularly monitor blood routine and liver function indicators to ensure the efficacy and safety of the drug. For patients receiving initial treatment or long-term maintenance treatment, domestic drugs are widely used due to their higher accessibility and economy, while imported drugs are more suitable for special cases or patients' personal preferences.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)